Search alternatives:
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
response decrease » response defense (Expand search)
acuity response » acute response (Expand search), immunity response (Expand search), auditory response (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease any » decrease and (Expand search), decreases and (Expand search), decreased and (Expand search)
any decrease » and decrease (Expand search), can decrease (Expand search), may decrease (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
response decrease » response defense (Expand search)
acuity response » acute response (Expand search), immunity response (Expand search), auditory response (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease any » decrease and (Expand search), decreases and (Expand search), decreased and (Expand search)
any decrease » and decrease (Expand search), can decrease (Expand search), may decrease (Expand search)
1
2
3
“..., 600, and 800 kPa at 13 ± 1°C) for 4 or 8 d, promotes any improvement compared to conventional...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
4
5
6
“... OK treatment does not affect objectively measured the accommodative response of young, low myopic eyes after...”
Access document
Access document
Article
7
“... to ranibizumab or aflibercept. Best-corrected visual acuity (BCVA) and central foveal thickness (CFT) were...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
8
“... to ranibizumab or aflibercept. Best-corrected visual acuity (BCVA) and central foveal thickness (CFT) were...”
Access document
Access document
Article
9
“.../by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any...”
Access document
Access document
Article
10
11
“... with worse visual acuity. Fifteen days after treatment patient reported better visual acuity on the...”
Access document
Access document
Article
12
13
14
15
16
17
“... functional and anatomical outcomes after monthly intravitreal bevacizumab for the treatment of macular edema...”
Access document
Access document
Article
18
19
“... methods for monitoring the invasion processes. We analyzed the morphological differences between a wild...”
Access document
Access document
Article
20
“... performance at tasks that assessed mental imagery processes after arousal increase after subjects’ exposure...”
Access document
Access document
Article